IMVT · Forms 3, 4, 5

Insider trades at Immunovant, Inc.

4 insiders sold $460K of Immunovant, Inc. stock on the open market in the last 30 days.

Every Form 3, 4 and 5 filed for Immunovant, Inc. (IMVT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Jay S StoutChief Technology OfficerSell2,213$32.06$71KForm 4
Jay S StoutChief Technology OfficerSell1,596$32.06$51KForm 4
Tuyl Christopher VanChief Legal OfficerSell1,327$32.06$43KForm 4
Melanie GloriaChief Operating OfficerSell2,241$32.06$72KForm 4
Eric VenkerChief Executive OfficerSell3,506$34.11$120KForm 4
Eric VenkerChief Executive OfficerOption exercise92,187$14.46$1.3MForm 4
Eric VenkerChief Executive OfficerReturned to company85,886$33.65$2.9MForm 4
Tuyl Christopher VanChief Legal OfficerSell2,846$36.36$103KForm 4
Atul PandeDirectorOption exercise1,500$8.43$13KForm 4
Atul PandeDirectorSell1,500$43.27$65KForm 4
Melanie GloriaChief Operating OfficerSell3,056$44.16$135KForm 4
Atul PandeDirectorOption exercise1,500$8.43$13KForm 4
Atul PandeDirectorSell1,500$39.80$60KForm 4
Tiago GiraoChief Financial OfficerSell6,798$38.69$263KForm 4
Jay S StoutChief Technology OfficerSell2,857$38.69$111KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.